Amgen's fast-growing cancer immunotherapy Imdelltra could move into the first-line setting in small cell lung cancer (SCLC), ...

The pivotal QUINTESSENTIAL trial of the potentially first-in-class CAR-T showed a "statistically significant and clinically ...

The FDA has started a priority review of AstraZeneca's IL-33-targeting antibody tozorakimab for chronic obstructive pulmonary ...

An AI-powered imaging tool developed by Brainomix has been used to enrich data from a phase 2a trial of Endeavor BioMedicines ...

Registration and the full programme are available on the DIA-MHRA Global Summit page. Follow the conversation at ...

Every few years, drug development goes through a moment where a new technology promises to change everything. Artificial ...

Different regions have distinct healthcare systems, varying access levels, reimbursement models, and treatment realities — ...

Blood disorder specialist Fulcrum Therapeutics has agreed to what amounts to a reverse merger with Slate Medicines, a privately held biotech focused on next generation therapies for migraine. The ...

CVS Pharmacy quietly shuttered its SimpleDose multi-dose packaging offering at the end of March. The offering, which competed with services like Amazon's PillPack, was ended quietly and abruptly, with ...

Belgian biotech Galapagos is mixing things up again via a plan to split in two, separating its innovative medicines and cell therapy businesses, which will result in the loss of around 300 jobs or ...

As cell therapy for autoimmune disease transitions from breakthrough clinical case studies to broad clinical validation, developers are racing to overcome challenges around safety, scalability, ...

Uniting leaders pioneering complement-targeted therapies across ophthalmology, neurodegeneration, nephrology, oncology and ...